CANF

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares
CANF

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$3.25
19% downside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
D. Boral Capital
D. Boral Capital
Jason Kolbert
27% 1-yr CANF win rate
17 Dec ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Swayampakula Ramakanth
100% 1-yr CANF win rate
4 Nov ‘25 2 months ago